» Articles » PMID: 31506816

A CT-based Radiomics Nomogram for Differentiation of Renal Angiomyolipoma Without Visible Fat from Homogeneous Clear Cell Renal Cell Carcinoma

Overview
Journal Eur Radiol
Specialty Radiology
Date 2019 Sep 12
PMID 31506816
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To develop and validate a radiomics nomogram for preoperative differentiating renal angiomyolipoma without visible fat (AML.wovf) from homogeneous clear cell renal cell carcinoma (hm-ccRCC).

Methods: Ninety-nine patients with AML.wovf (n = 36) and hm-ccRCC (n = 63) were divided into a training set (n = 80) and a validation set (n = 19). Radiomics features were extracted from corticomedullary phase and nephrographic phase CT images. A radiomics signature was constructed and a radiomics score (Rad-score) was calculated. Demographics and CT findings were assessed to build a clinical factors model. Combined with the Rad-score and independent clinical factors, a radiomics nomogram was constructed. Nomogram performance was assessed with respect to calibration, discrimination, and clinical usefulness.

Results: Fourteen features were used to build the radiomics signature. The radiomics signature showed good discrimination in the training set (AUC [area under the curve], 0.879; 95%; confidence interval [CI], 0.793-0.966) and the validation set (AUC, 0.846; 95% CI, 0.643-1.000). The radiomics nomogram showed good calibration and discrimination in the training set (AUC, 0.896; 95% CI, 0.810-0.983) and the validation set (AUC, 0.949; 95% CI, 0.856-1.000) and showed better discrimination capability (p < 0.05) compared with the clinical factor model (AUC, 0.788; 95% CI, 0.683-0.893) in the training set. Decision curve analysis demonstrated the nomogram outperformed the clinical factors model and radiomics signature in terms of clinical usefulness.

Conclusions: The CT-based radiomics nomogram, a noninvasive preoperative prediction tool that incorporates the Rad-score and clinical factors, shows favorable predictive efficacy for differentiating AML.wovf from hm-ccRCC, which might assist clinicians in tailoring precise therapy.

Key Points: • Differential diagnosis between AML.wovf and hm-ccRCC is rather difficult by conventional imaging modalities. • A radiomics nomogram integrated with the radiomics signature, demographics, and CT findings facilitates differentiation of AML.wovf from hm-ccRCC with improved diagnostic efficacy. • The CT-based radiomics nomogram might spare unnecessary surgery for AML.wovf.

Citing Articles

Predicting major adverse cardiovascular events in angina patients using radiomic features of pericoronary adipose tissue based on CCTA.

Zhan W, Luo Y, Luo H, Zhou Z, Yin N, Li Y Front Cardiovasc Med. 2024; 11:1462451.

PMID: 39544308 PMC: 11560751. DOI: 10.3389/fcvm.2024.1462451.


A CT-based radiomics nomogram for predicting histologic grade and outcome in chondrosarcoma.

Li X, Shi X, Wang Y, Pang J, Zhao X, Xu Y Cancer Imaging. 2024; 24(1):50.

PMID: 38605380 PMC: 11007871. DOI: 10.1186/s40644-024-00695-7.


Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study.

Chen W, Lin G, Chen Y, Cheng F, Li X, Ding J BMC Cancer. 2024; 24(1):418.

PMID: 38580939 PMC: 10996101. DOI: 10.1186/s12885-024-12026-x.


The radiomics-clinical nomogram for predicting the response to initial superselective arterial embolization in renal angiomyolipoma, a preliminary study.

Zechuan L, Tianshi L, Tiantian L, Shoujin C, Hang Y, Ziping Y Front Oncol. 2024; 14:1334706.

PMID: 38505597 PMC: 10949893. DOI: 10.3389/fonc.2024.1334706.


Radiomics nomogram for preoperative differentiation of early-stage serous borderline ovarian tumors and serous malignant ovarian tumors.

Yu X, Zou Y, Wang L, Yang H, Jiao J, Yu H Front Oncol. 2024; 13:1269589.

PMID: 38288103 PMC: 10822955. DOI: 10.3389/fonc.2023.1269589.


References
1.
Lee H, Hong H, Jung D, Park S, Kim J . Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification. Med Phys. 2017; 44(7):3604-3614. DOI: 10.1002/mp.12258. View

2.
Shu J, Tang Y, Cui J, Yang R, Meng X, Cai Z . Clear cell renal cell carcinoma: CT-based radiomics features for the prediction of Fuhrman grade. Eur J Radiol. 2018; 109:8-12. DOI: 10.1016/j.ejrad.2018.10.005. View

3.
Shinagare A, Krajewski K, Braschi-Amirfarzan M, Ramaiya N . Advanced Renal Cell Carcinoma: Role of the Radiologist in the Era of Precision Medicine. Radiology. 2017; 284(2):333-351. DOI: 10.1148/radiol.2017160343. View

4.
Vos N, Oyen R . Renal Angiomyolipoma: The Good, the Bad, and the Ugly. J Belg Soc Radiol. 2018; 102(1):41. PMC: 6032655. DOI: 10.5334/jbsr.1536. View

5.
Kunapuli G, Varghese B, Ganapathy P, Desai B, Cen S, Aron M . A Decision-Support Tool for Renal Mass Classification. J Digit Imaging. 2018; 31(6):929-939. PMC: 6261185. DOI: 10.1007/s10278-018-0100-0. View